A simplified and highly efficient cell-free protein synthesis system for prokaryotes
eLife Assessment
The study presents valuable findings of a new E. coli cell-free protein synthesis (eCFPS) system that has been simplified by reducing the number of core components from 35 to 7; furthermore, the findings communicate a simplified ‘fast lysate’ preparation that eliminates the need for traditional runoff and dialysis steps. The system's robustness is exhibited by its applicability to nanoluc, a ubiquitous protein and to more challenging proteins like vimentin and the active restriction endonuclease BsaI. The evidence is convincing and supports the main claims on efficiency backed up by investigations on the mechanisms. The paper will be of interest to scientists in cell and molecular biology, microbiology, biotechnology, and protein synthesis.
https://doi.org/10.7554/eLife.109495.5.sa0Valuable: Findings that have theoretical or practical implications for a subfield
- Landmark
- Fundamental
- Important
- Valuable
- Useful
Convincing: Appropriate and validated methodology in line with current state-of-the-art
- Exceptional
- Compelling
- Convincing
- Solid
- Incomplete
- Inadequate
During the peer-review process the editor and reviewers write an eLife Assessment that summarises the significance of the findings reported in the article (on a scale ranging from landmark to useful) and the strength of the evidence (on a scale ranging from exceptional to inadequate). Learn more about eLife Assessments
Abstract
Cell-free protein synthesis (CFPS) systems are a powerful platform with immense potential in fundamental research, biotechnology, and synthetic biology. Conventional prokaryotic CFPS systems, particularly those derived from Escherichia coli, often rely on complex reaction buffers containing up to 35 components, limiting their widespread adoption and systematic optimization. Here, we present an optimized E. coli cell-free protein synthesis (eCFPS) system, which is significantly streamlined for high efficiency. Through systematic screening, we successfully reduced the essential core reaction components from 35 to a core set of 7. The thorough optimization of these seven key components ensured that protein expression levels were not only maintained but even substantially improved. Furthermore, we developed a much simpler procedure for preparing the bacterial cytosolic extracts, a ‘fast lysate’ protocol that eliminates the traditional time-consuming runoff and dialysis steps, thereby enhancing the overall accessibility and robustness of eCFPS. This optimized and user-friendly eCFPS efficiently synthesizes challenging proteins, including functional, self-assembling vimentin, and active restriction endonuclease BsaI despite its strong cytotoxicity, and serves as a powerful tool that will facilitate diverse applications in basic life science research and beyond.
Introduction
Cell-free protein synthesis (CFPS) offers a powerful and flexible platform for biological research and biotechnological applications by reproducing the cellular protein synthesis process in an in vitro environment (Carlson et al., 2012; Katzen et al., 2005). Compared to traditional cell-based expression systems, CFPS possesses several notable advantages, including rapid reaction kinetics, ease of operation, independence from cell culture, high tolerance to toxic proteins, and facile incorporation of non-canonical amino acids (Martin et al., 2018; Liu and Schultz, 2010; Dumas et al., 2015). These characteristics position CFPS for broad applications in protein engineering, high-throughput screening, synthetic biology, and diagnostic reagent development (Guzman-Chavez et al., 2022; Gregorio et al., 2019).
Prokaryotic CFPS systems, especially those based on Escherichia coli lysates, have garnered significant attention for their high protein synthesis yields and compatibility with genetic manipulations (Jiang et al., 2021; Xu et al., 2020; Zemella et al., 2015; Jiang et al., 2018; Endoh et al., 2006; Ji et al., 2025). They have played a pivotal role in early molecular biology research and continue to be relevant in industrial protein production and biosensor development (Carlson et al., 2012; Gao et al., 2018; Lee and Kim, 2018; Meng et al., 2023). However, for a long time, most prokaryotic CFPS protocols have relied on complex buffer systems containing a large number of auxiliary components (Kigawa et al., 1999; Kim et al., 2020). A comprehensive analysis of existing literature reveals that the composition of reaction buffers differs widely between protocols, both in the number of optional components and in the concentrations of individual components (Supplementary file 1). These complex systems, while effective, often lead to high costs, laborious preparation procedures, and potential interactions among components, posing significant challenges for further optimization and standardization, thereby limiting their widespread adoption in resource-constrained laboratories.
In recent years, the field of eukaryotic CFPS has seen remarkable progress in system optimization and simplification (Bothe and Ban, 2024; Aleksashin et al., 2023). Highly optimized human in vitro translation systems have demonstrated that high-efficiency protein synthesis can be achieved with a minimal number of core components (Bothe and Ban, 2024). Recognizing the potential of such systematic optimization approaches, we hypothesized that similar strategies could be equally applicable and beneficial for E. coli CFPS systems by thoroughly analyzing the functions of existing components and integrating insights from previous reports on prokaryotic protein synthesis mechanisms. This study aimed to develop a highly simplified yet efficient E. coli cell-free protein synthesis system (eCFPS). We conducted a systematic component reduction screening of traditional eCFPS systems, successfully streamlining the core components from 35 to just 7. The subsequent meticulous optimization of these seven key components not only maintained but even improved protein expression levels. Through these dual efforts—simplifying the reaction mixture and developing a high-quality, dialysis-free ‘fast lysate’ preparation—we established a highly accessible and robust eCFPS platform which will accelerate diverse applications in life science research.
Results
Streamlining eCFPS: Removal of dispensable components
To develop a more streamlined and efficient eCFPS system, we performed a systematic screening of auxiliary components commonly found in traditional prokaryotic CFPS protocols (Kigawa et al., 1999; Levine et al., 2019). Our objective was to identify dispensable components while maintaining or enhancing protein synthesis efficiency, thereby simplifying system preparation and reducing costs. Starting with a comprehensive reaction mixture containing up to 35 components (Kigawa et al., 1999), we iteratively evaluated the contribution of individual constituents through luciferase reporter assays. Throughout this optimization, essential core components such as creatine phosphate (CrP), creatine kinase (CrK), ATP, GTP, magnesium, and potassium were maintained in the base reaction mixture (Martin et al., 2018; Jiang et al., 2021; Bothe and Ban, 2024). Our systematic approach allowed us to precisely determine the impact of each component on overall protein synthesis yield, leading to the identification of both dispensable and critical factors.
Through this systematic screening, we first identified several components that could be entirely removed from the reaction mixture without compromising protein synthesis efficiency (Figure 1). Dithiothreitol (DTT), a reducing agent commonly included in both transcription and translation systems to maintain protein sulfhydryl groups in a reduced state and prevent aggregation, was found to be unnecessary within our specific system, as its removal did not affect the final protein expression levels (Figure 1A). Similarly, cyclic adenosine 3′,5′-monophosphate (cAMP), a regulator implicated in transcriptional regulation (Sands and Palmer, 2008; Daniel et al., 1998; Boshart et al., 1990), was also found to be dispensable for efficient protein synthesis (Figure 1B). Furthermore, we systematically evaluated other auxiliary components, including the molecular crowder polyethylene glycol 8000 (PEG8000), used to enhance macromolecular crowding (Chu et al., 2023; Ge et al., 2011; Liebau et al., 2024; Paudel et al., 2018; Zhang et al., 2021); ammonium ions (NH4+), typically included as an osmolyte and for its role in maintaining protein stability and solubility in eCFPS reactions (Zhang et al., 2021; Auton et al., 2011; Mojtabavi et al., 2019; Hunt et al., 2025; Cai et al., 2015); and folinic acid, which serves as a crucial cofactor for nucleotide synthesis (Jiang et al., 2021; Cai et al., 2015). Our results consistently showed that removing these components had a negligible impact on overall protein synthesis performance (Figure 1C–E). These findings collectively demonstrate that a substantial portion of the auxiliary components in traditional eCFPS protocols can be eliminated, paving the way for a more streamlined and cost-effective system.
Optimization of eCFPS components.
Protein expression levels from the eCFPS system were measured using a Nanoluciferase (NLuc) reporter DNA. Green area in the graphs indicate the common concentration range used in published protocols for eCFPS. Error bars represent the standard error (SE) of at least three independent reactions. (A–E) Protein expression levels of the eCFPS system supplemented with different concentrations of DTT (A), cAMP (B), PEG8000 (C), NH4+ (D), and folinic acid (E). Data present mean ± SEM, n=3 independent biological replicates. (F–I) Protein expression levels of eCFPS with various concentrations of tRNA (F), amino acids (G), CTP (H), and UTP (I). Data present mean ± SEM, n=3 independent biological replicates. (J) A summary of the supplement components before and after optimization. The quantitative data underlying the plots in this figure are provided in Figure 1—source data 1.
-
Figure 1—source data 1
Plotted values in panels A—I.
- https://cdn.elifesciences.org/articles/109495/elife-109495-fig1-data1-v1.xlsx
An evaluation of various concentrations of amino acids and tRNA was conducted, as these components are fundamental building blocks for protein synthesis (Anderson, 1969; Deutscher, 1984; Rodnina, 2018). Previous studies on eCFPS have highlighted the rapid degradation of certain amino acids, such as arginine, cysteine, and tryptophan, necessitating their replenishment for prolonged synthesis (Kim and Swartz, 2000; Kim and Swartz, 1999). Our results showed that while these components are critical for achieving high yields, protein synthesis still occurs in their absence (Figure 1F and G). This suggests that while they are optimizable, tRNA and amino acids are not strictly essential for the reaction to proceed, likely due to residual amounts within the cell lysate (Figure 1F and G). Furthermore, we evaluated the role of nucleoside triphosphates (NTPs) in our system, which are essential for coupled transcription-translation. Interestingly, we found that protein synthesis could proceed without the addition of CTP or UTP (Figure 1H and I and Figure 1—figure supplement 1A). While adding either ATP or GTP alone resulted in a very weak reaction, the presence of both ATP and GTP together recovered the reaction to approximately 40% of the complete NTPs mix (Figure 1—figure supplement 1B and C). This highlights the critical role for ATPase-dependent chaperones (e.g., DnaK) and GTPase-dependent elongation factors (e.g., EF-Tu and EF-G; Agirrezabala and Frank, 2009), which are crucial for proper protein folding during synthesis (Mayer, 2021).
Ultimately, this comprehensive screening allowed us to successfully reduce the core reaction components from 35 to just 7 (Figure 1J).
Optimization of essential eCFPS components
While a core set of seven components was found to be sufficient for protein synthesis, we conducted further fine-tuning to maximize the system’s performance. First, we optimized the concentrations of key salts and energy components (Figure 2). Our findings reveal that the final protein expression level is highly dependent on the concentrations of both magnesium (Mg2+) and potassium ions (K+), which are fundamental for the structural integrity and catalytic activity of ribosomes, and various enzymatic reactions critical to eCFPS (Nierhaus, 2014; Gesteland, 1966). Through a detailed matrix-based optimization, we first identified the optimal concentrations of Mg2+ and K+ to achieve maximum protein expression (Figure 2A). Similarly, we conducted a separate screen to optimize the concentrations of Mg2+ and PEG8000 as previous reports have suggested a cooperative relationship between them (Kigawa et al., 1999; Figure 2B).
Optimization of essential components for eCFPS system.
(A) Protein expression levels of the eCFPS system measured at varying concentrations of KGlu and MgGlu2. (B) Protein expression levels of the eCFPS system measured at varying concentrations of MgGlu2 and PEG8000. (C) Protein expression levels of the eCFPS system measured at varying concentrations of ATP and GTP. (D) Protein expression levels of the eCFPS system measured at varying concentrations of CrK and CrP. (E) Protein expression levels of the eCFPS system measured at varying pH and buffer concentrations. Data from all panels present mean ± SEM, n=3 independent biological replicates. The quantitative data underlying the plots in this figure are provided in Figure 2—source data 1.
-
Figure 2—source data 1
Plotted values in panels A—E.
- https://cdn.elifesciences.org/articles/109495/elife-109495-fig2-data1-v1.xlsx
A comprehensive evaluation of the core energy components was also performed. We specifically focused on co-optimizing the concentrations of ATP and GTP, which serve as both energy sources and building blocks (Espinasse et al., 2020; Calhoun and Swartz, 2005; Sitaraman et al., 2004), to maximize the yield of protein synthesis (Figure 2C). Additionally, the energy regeneration system, primarily composed of CrP and CrK, is vital for maintaining sustained ATP levels (Gaddi et al., 2017; Wallimann et al., 2011). We found that CrP is crucial, with no reaction occurring in its absence (Figure 2—figure supplement 1A). Initial experiments showed that while CrK addition significantly boosted translation efficiency early on, reactions without exogenous CrK could achieve a protein expression level approximately four times higher at later time points (2 h or more), suggesting the presence of an endogenous CrK-like enzyme in the lysate (Figure 2—figure supplement 1B). A co-optimization screen for CrP and CrK concentrations was also performed, and our results showed that optimizing the concentrations of these components is critical for achieving and sustaining high protein expression (Figure 2D). Furthermore, we optimized the pH and concentration of the HEPES buffer, finding that a specific range was critical for maintaining stable and high protein expression (Figure 2E). These multifaceted optimizations ensured that each component was present at its ideal concentration, leading to a synergistic effect that significantly boosted the system’s overall performance.
Performance characterization of the optimized eCFPS
To thoroughly evaluate the performance of our optimized eCFPS, we conducted a series of experiments. We first investigated the kinetics of protein synthesis, measuring the expression over time at different temperatures (25°C, 30°C, and 37°C). Our results demonstrate that the system exhibits robust protein synthesis across this range, with the highest expression rates observed at the physiological temperature of 37°C (Figure 3A). Next, we assessed the system’s sensitivity to DNA concentration, finding that it could efficiently utilize a wide range of reporter DNA templates to produce quantifiable protein products, which were validated by both luminescence assays and western blot analysis (Figure 3B). Furthermore, we investigated the impact of varying cell lysate volume ratios, comparing our initial system with the newly optimized eCFPS. Our findings indicate that the optimized system maintains superior protein expression even at different lysate-to-buffer ratios (Figure 3C).
Characterization of the optimized eCFPS system.
(A) Kinetics of protein synthesis at 25°C, 30°C, and 37°C over a 60-min period. Data presented as mean ± SEM; n=3 independent biological replicates. (B) Protein expression levels of the eCFPS system measured at varying DNA concentrations for a reporter encoding a FLAG-tagged NLuc. The protein product was quantified via a luminescence assay and confirmed by western blotting (upper panel). Data presented as mean ± SEM; n=3 independent biological replicates. (C) Comparison of protein yield. The 'initial' system denotes the traditional 35-component reaction mixture prior to optimization, serving as a baseline control for benchmarking the streamlined system. Data presented as mean ± SEM; n=4 independent biological replicates. Statistical analysis was performed using unpaired t‑test, , with each optimized group compared against the initial control. All optimized lysate groups yielded significantly higher values than the initial group (P < 0.0001). Original blots and annotated blot images corresponding to (B) are provided in Figure 3—source data 1 and Figure 3—source data 2, respectively. The quantitative data underlying the plots in this figure are provided in Figure 3—source data 3.
-
Figure 3—source data 1
Original files for western blot analysis displayed in Figure 3B.
- https://cdn.elifesciences.org/articles/109495/elife-109495-fig3-data1-v1.zip
-
Figure 3—source data 2
PDF files containing original western blots for Figure 3B, indicating the relevant bands.
- https://cdn.elifesciences.org/articles/109495/elife-109495-fig3-data2-v1.zip
-
Figure 3—source data 3
Plotted values in panels A—C.
- https://cdn.elifesciences.org/articles/109495/elife-109495-fig3-data3-v1.xlsx
To distinguish whether the increased protein expression in the optimized system was due to enhanced transcription or translation, we conducted assays using both DNA and pre-transcribed mRNA templates. The results (Figure 3—figure supplement 1A) indicate that while the translation efficiency in the streamlined system showed a slight decrease compared to the initial system, the significant improvement in transcription efficiency resulted in a higher overall protein yield. Direct quantification via RT-qPCR revealed a remarkable increase in transcript levels in our optimized system compared to the standard initial system (Figure 3—figure supplement 1B). Notably, even when the initial system was supplemented with excess T7 RNA polymerase (400 ng/µL), the accumulated transcript levels remained substantially lower than those of our optimized system. Furthermore, T7 RNA polymerase titration confirmed that the initial system saturates at 800 ng/µL—a concentration nearly 10 times higher than standard protocols (~90–100 ng/µL)—while remaining ~45-fold less productive than our optimized system (Figure 3—figure supplement 1C).
Benchmarking and expression of challenging proteins
We benchmarked our system against two widely used systems: the classical phosphoenolpyruvate (PEP)-based system and our 35-component initial CrP/CrK-based system (Guzman-Chavez et al., 2022; Gregorio et al., 2019; Figure 4). We utilized NLuc, representing a broadly applicable protein, and super-folder green fluorescent protein (sfGFP), with codons optimized for E. coli as reporter proteins and monitored their expression over time (Figure 4A and B, Figure 4—figure supplement 1A). Our results show that the optimized eCFPS consistently outperforms both the classical and initial systems, achieving significantly higher protein expression levels in a shorter period (Figure 4A and B). The robust expression was further confirmed by western blot analysis, which provided clear visual evidence of the superior protein yield from our optimized system (Figure 4C and D, Figure 4—figure supplement 1B and C). Finally, we validated the function of our system through antibiotic-mediated inhibition assays. Our results demonstrate that protein expression in the optimized eCFPS can be effectively inhibited by standard antibiotics, confirming its robust and native-like translation machinery (Figure 4—figure supplement 1D).
Benchmarking and expression of challenging proteins.
(A) NLuc protein expression kinetics over time, comparing the PEP-based, initial CrP/CrK-based, and optimized CrP/CrK-based energy regeneration systems. Data present mean ± SEM, n=4 independent biological replicates. Statistical analysis was performed using unpaired t‑tests. The optimized system was significantly higher than both initial and PEP‑based groups across 10 min, 30 min and 60 min time points (P < 0.0001). (B) sfGFP protein expression kinetics over time from the three energy regeneration systems. Data present mean ± SEM, n=3 independent biological replicates. Statistical analysis was performed using unpaired t‑tests. The optimized system was significantly higher than both initial and PEP‑based groups across 10 min, 30 min and 60 min time points (P < 0.0001). (C, D) Western blot validation of protein expression for NLuc (C) and sfGFP (D) from the different eCFPS system shown in (A, B). Protein products were detected using an anti-FLAG antibody. The asterisk (*) indicates a non-specific band. (E) Western blot detection of His-FLAG-BsaI expressed by the optimized eCFPS system using an anti-FLAG antibody. (F) Agarose gel electrophoresis confirming the functional activity of eCFPS-synthesized BsaI via cleavage of a substrate plasmid. A 10-fold serial dilution of BsaI was with 1x representing 0.05 mg/mL. NC (negative control) indicates no plasmid in the eCFPS reaction. S, L, and O indicate the respective position of the supercoiled, linear, and open circular forms of the plasmid. (G) Western blot analysis of vimentin expressed by the optimized eCFPS system using an anti-vimentin antibody. (H) Negative-stain electron microscopy image showing that vimentin expressed via eCFPS can successfully self-assemble into filaments in vitro. Scale bars: 500 nm (main panel), 200 nm (inset panels). Original blots and annotated blot images corresponding to Figure 4C/D/E/F/G are provided in Figure 4—source data 1 and Figure 4—source data 2, respectively. The quantitative data underlying the plots are provided in Figure 4—source data 3.
-
Figure 4—source data 1
Original files for western blot analysis displayed in Figure 4C, D, E, G.
- https://cdn.elifesciences.org/articles/109495/elife-109495-fig4-data1-v1.zip
-
Figure 4—source data 2
PDF files containing original western blots for Figure 4C, D, E, G, indicating the relevant bands.
- https://cdn.elifesciences.org/articles/109495/elife-109495-fig4-data2-v1.zip
-
Figure 4—source data 3
Plotted values in panels A and B.
- https://cdn.elifesciences.org/articles/109495/elife-109495-fig4-data3-v1.xlsx
To further validate the system’s capability in synthesizing challenging, functional proteins, we focused on the restriction endonuclease BsaI (Figure 4E and F). Restriction endonucleases like BsaI are notoriously difficult to express in vivo due to their specific DNA-cleaving activity, which is highly cytotoxic to the host E. coli cells. Traditional recombinant expression requires the compulsory co-expression of a corresponding methylase to protect the host genome, adding significant complexity to the system (Hochuli et al., 1988; Watanabe et al., 2009). Leveraging the inherent cell-free advantage of circumventing cytotoxicity, we first demonstrated the system’s utility by synthesizing the restriction endonuclease BsaI (Danna and Nathans, 1971), confirming its specific enzymatic activity via a DNA cleavage assay, which underscores the system’s ability to produce complex, functional enzymes (Figure 4E and F). We confirmed that the eCFPS synthesized BsaI was functionally active, successfully cleaving its substrate plasmid DNA (Figure 4F). Based on the standard definition of enzyme activity (1U digests 1 μg of substrate DNA in 20 μL at 37°C in 1 h), we calculated the enzyme activity of our eCFPS-produced BsaI to be in the range of 2×103 to 2×104 U/mg (Figure 4F). The efficient production of this active enzyme demonstrates the power of our simplified system for producing complex, cytotoxic proteins.
Next, we successfully expressed vimentin, an intermediate filament protein (Figure 4G). Vimentin is a type III intermediate filament protein that forms part of the cytoskeleton (Eibauer et al., 2024). It is known to be difficult to express and handle due to its high propensity for aggregation. Our eCFPS system efficiently expressed vimentin (Figure 4G). Crucially, the vimentin expressed in our CFPS system demonstrated successful in vitro self-assembly into filaments (Figure 4H), which was confirmed by negative-stain electron microscopy, confirming the system’s robust performance even for difficult-to-express, aggregation-prone proteins (Figure 4E–H). We also benchmarked the absolute productivity of our optimized system against a high-end commercial cell-free system using sfGFP (Figure 4—figure supplement 1G). The optimized system achieved an absolute yield of 0.46 mg/mL, significantly outperforming the commercial alternative (approximately 0.21 mg/mL).
A simplified method for bacterial lysate preparation and quality control
In addition to optimizing the reaction buffer, we sought to simplify the entire eCFPS procedure by developing an easy-to-use method for preparing the bacterial cell lysate. During lysate making, traditional methods, which often rely on time-consuming runoff and dialysis procedures (Levine et al., 2019; Jiang et al., 2021), were replaced with a high-pressure homogenizer for efficient cell disruption, eliminating the need for additional dialysis. Compared to traditional biochemical methods such as ultrasonication, lysozyme treatment, or freeze–thaw cycles (Fujiwara and Doi, 2016), this approach is faster and more convenient (Figure 5A). Additionally, endogenous T7 RNA polymerase in the optimized eCFPS lysate obviates exogenous addition, simplifying preparation and reducing costs while maintaining high translation efficiency (Figure 5A). We validated this new ‘fast lysate’ preparation by rigorous quality control. We tested lysates prepared from cells harvested at various optical densities at 600 nm (OD600). While the density did not significantly impact protein expression levels, a harvest optical density of OD600=2 yielded the best performance (Figure 5B). The quality of the lysate, particularly the integrity of its translational machinery, was further confirmed by sucrose gradient centrifugation (Figure 5—figure supplement 1A) and negative-staining transmission electron microscopy (TEM) images (Figure 5—figure supplement 1B) showing well-resolved 70S ribosomes.
Preparation of eCFPS from cultured E. coli cells.
(A) Flowchart of the eCFPS preparation procedures. (B) Comparison of reaction efficiency in eCFPS using lysate with bacteria cells harvested at different optical density. Data present mean ± SEM, n=3 independent biological replicates. (C) Sucrose gradient sedimentation analysis of different lysates used for eCFPS, revealing the presence of ribosome monomers. (D) Comparison of protein expression levels in eCFPS system using lysates prepared by runoff, dialysis, and rapid endogenous T7 RNA polymerase induction. Data present mean ± SEM, n=4 independent biological replicates. Statistical analysis was performed using unpaired t‑tests. The fast lysate (rapid endogenous T7 induction) group exhibited significantly higher units than both the runoff and dialysis groups (P < 0.0001). (E) Comparison of reaction efficiency in eCFPS using lysates after different numbers of freeze–thaw cycles. Data present mean ± SEM, n=3 independent biological replicates. The quantitative data underlying the plots are provided in Figure 5—source data 1.
-
Figure 5—source data 1
Plotted values in panels B—E.
- https://cdn.elifesciences.org/articles/109495/elife-109495-fig5-data1-v1.xlsx
To further simplify the protocol, we evaluated the necessity of the traditional runoff and dialysis steps (Jiang et al., 2021; Figure 5A). Our results from sucrose gradient analysis and TEM imaging confirmed that ribosomes remained intact, and the eCFPS expression signal was significantly higher without them (Figure 5C and D, Figure 5—figure supplement 1B). These findings confirm that both the runoff and dialysis steps are dispensable for our system, allowing for a significantly simplified and faster preparation. Additionally, our reliance on endogenously expressed T7 RNA polymerase yields a significantly higher expression signal, outperforming previously reported eCFPS systems by up to fourfold (Figure 5D).
Our optimized lysate preparation method yielded highly active and stable extracts. It is capable of sustaining protein synthesis for up to 120 min (Figure 5—figure supplement 1C) and maintains protein synthesis efficiency even after multiple freeze–thaw cycles, making it highly suitable for routine laboratory use (Figure 5E).
Discussion
This study presents a streamlined and highly efficient eCFPS platform achieved by reducing the reaction components from 35 to 7. The performance of this simplified system was evaluated against the initial 35-component setup and PEP-based platforms, which serve as established reference baselines. The improvement in protein yield over these comparative standards, coupled with stable absolute productivity, supports the efficacy of the optimized reaction buffer and lysate preparation.
A notable finding was the ability of our system to function effectively without several components traditionally considered essential, which we attribute to the metabolic capacity of the fast lysate. By bypassing traditional runoff and dialysis steps, this protocol preserves active endogenous enzymes capable of synthesizing building blocks from residual precursors. For instance, functional pathways for synthesizing specific amino acids, such as deriving Cys and Trp from Ser, and generating Asn and Gln from Asp and Glu, are maintained (Yokoyama et al., 2010). Similarly, endogenous nucleotide metabolic enzymes, powered by the CrP/CrK regeneration system, convert residual pools into functional CTP and UTP to support coupled transcription and translation (Weng et al., 1986). Further analysis indicates that the performance gain is primarily driven by enhanced transcription, which more than compensates for a modest reduction in translational efficiency in the streamlined environment. This improvement does not stem from a simple increase in T7 RNA polymerase availability; instead, it reflects a systemic synergy where the streamlined buffer and the optimized metabolic environment of the lysate together alleviate transcriptional bottlenecks inherent in traditional platforms. This systemic rescue of transcription is directly supported by our RT-qPCR analysis, which confirmed that relieving buffer complexity, rather than merely increasing polymerase dosage, is key to overcoming transcriptional bottlenecks. Ultimately, this metabolic self-sufficiency, combined with the preservation of critical endogenous factors through the omission of dialysis, maintains the lysate in a highly active state that permits significant simplification of the reaction chemistry while driving superior performance.
The applicability of the optimized eCFPS was tested through the synthesis of targets beyond standard reporters. The production of active BsaI restriction enzyme, a cytotoxic and difficult-to-express protein, and the functional assembly of vimentin, a difficult-to-handle intermediate filament protein (Eibauer et al., 2024), further validate the superior robustness and translational quality of our optimized system.
Despite its efficiency, certain limitations are acknowledged. As a prokaryotic platform, it lacks the eukaryotic chaperone systems (e.g., Hsp70/Hsp90 families) and post-translational modification (PTM) machinery required for many human proteins (Zemella et al., 2015). While we demonstrated that DTT is dispensable for the targets tested here, specialized cysteine-rich proteins may still require exogenous reducing agents to ensure proper folding. Furthermore, while the fast lysate protocol significantly lowers the barrier to entry, the expression of certain membrane proteins will likely still require the systematic screening of detergents or synthetic lipids to ensure proper integration and stability. In conclusion, our optimized eCFPS system reduces reaction complexity while improving performance. By simplifying both the buffer composition and the lysate preparation procedure, we have established a cost-effective and user-friendly platform. This system is expected to facilitate high-throughput protein engineering, compound screening, and diagnostic development across the broader scientific community.
Methods
Plasmid construction
All plasmids and primers used in this study are detailed in Supplementary file 2. The NLuc and sfGFP reporter genes, each fused with a FLAG-tag, were cloned into a T7-driven expression vector. The sfGFP gene was optimized for E. coli codon usage to ensure efficient translation. The vector backbone was constructed using standard molecular biology techniques.
The BsaI linear DNA templates were constructed from three DNA fragments amplified by PCR. To enhance template stability and mitigate nuclease degradation within the CFPS system, approximately 300 bp sequences were incorporated upstream and downstream of the BsaI coding sequence. The fragments encoding the T7 promoter/upstream sequence (Fragment 1) and the T7 terminator/downstream sequence (Fragment 2) were amplified from the pJL1 plasmid. Separately, the gene fragment for the restriction endonuclease BsaI was amplified from the pUC_BsaI plasmid (Fragment 3). These three fragments were subsequently fused using overlap PCR to generate the final linear template, which was confirmed to lack the recognition sequence for the target BsaI enzyme.
E. coli cell culture and lysate preparation
E. coli S30 cell lysate for CFPS was prepared using a simplified protocol adapted from a previously reported method (Jiang et al., 2021). Briefly, E. coli BL21(DE3) was cultured in LB medium at 37°C with shaking. Once the OD600 reached 0.8, endogenous T7 RNA polymerase expression was induced with 1 mM IPTG. The culture was then grown for an additional 2 h before being harvested (when the OD600 reached 2–3). The cells were collected by centrifugation at 4000 g for 10 min at 4°C. The cell pellet was washed with 5 volumes of cold S30 buffer (10 mM HEPES-KOH pH 7.5, 14 mM Mg(OAc)2, 60 mM KOAc) and then resuspended in S30 buffer at a ratio of 1 mL per gram of wet cell paste. Cell lysis was performed using a high-pressure homogenizer at 800 bar for two passes. The lysate was then clarified by centrifugation at 20,000 × g for 10 min at 4°C, and the resulting supernatant, designated as the ‘fast lysate’, was collected without subsequent runoff or dialysis steps. This omission ensures maximal retention of endogenous components, contributing directly to the observed system efficiency. Lysate quality control was assessed by (i) sucrose density gradient analysis and negative-staining TEM to confirm the integrity of 70S ribosomes, and (ii) functional testing by monitoring the synthesis and activity of the challenging restriction enzyme, BsaI, and vimentin. Finally, the fast lysate was aliquoted and flash-frozen in liquid nitrogen before being stored at –80°C until use.
A step-by-step protocol is provided in the supplementary protocol.
eCFPS reactions for luciferase reporter assay
The optimized eCFPS reaction was performed in a 10 μL total volume containing the components listed in Supplementary files 3 and 4. Plasmid of NLuc reporter gene was used as the template.
Quantitative real-time PCR (RT-qPCR)
To evaluate the transcriptional levels of the NLuc reporter gene across different cell-free systems, quantitative real-time PCR (RT-qPCR) analysis was performed.
Each reaction was carried out in a total volume of 200 μL with a template plasmid concentration of 3.4 ng/μL. The reactions were incubated at 37°C for 30 min. A parallel 0 min reaction control was established as the baseline calibrator. Total RNA was extracted using the TRIzol reagent (Invitrogen) according to the manufacturer’s protocol, and the extracted RNA pellet was dissolved in an equal volume (900 μL) of nuclease-free water.
To synthesize cDNA, an equal volume (2 μL) of total RNA from each sample was reverse transcribed using the HiScript III 1st Strand cDNA Synthesis Kit (Vazyme, R312). To thoroughly rule out plasmid or genomic DNA contamination, no-template controls (NTC) and no-reverse transcriptase (no-RT) controls for all systems were prepared and analyzed in parallel. Quantitative real-time PCR was performed using the ChamQ SYBR Color qPCR Master Mix (Vazyme, Q411) on an Applied Biosystems Real-Time PCR System (Thermo Fisher Scientific) according to the manufacturer’s instructions. The relative fold changes of the NLuc transcript levels were calculated using the comparative 2-ΔΔCt method, with the 0 min sample of each group serving as the calibrator. All assays were performed with three independent biological replicates.
CFPS expression, protein purification, and analysis
Protein expression levels were quantified using NLuc and sfGFP reporter systems. NLuc activity was measured with the Nano-Glo luciferase assay system (Promega). Reaction mixtures were diluted as specified in the source data to prevent signal saturation and then analyzed on a microplate luminometer (BERTHOLD, Centro XS3 LB 960) to obtain the luminescence units as described previously (Li et al., 2019; Zhang et al., 2025). Relative Luciferase Units (RLU) were determined by normalizing the raw luminescence intensity of each experimental group to that of a designated control group (typically the ‘initial’ 35-component system). This normalization was performed by dividing the absolute signal of the sample by the mean signal of the control, allowing for consistency across different experimental batches and measurement sessions. sfGFP fluorescence was used to quantify protein synthesis following the methods reported (Wang et al., 2023). Briefly, 5 µL of the reaction mixture was added to 195 µL of fluorescence assay buffer (20 mM HEPES-KOH pH 7.5, 100 mM NaCl, 5 mM magnesium glutamate). Fluorescence was measured on a Cell Imaging Multimode Reader (BioTek, Cytation 5) with an excitation wavelength of 485 nm and an emission wavelength of 528 nm.
Western blotting analysis was performed to confirm protein synthesis of the eCFPS reactions. Synthesized proteins were detected using a primary anti-FLAG (Sigma, Cat#: M185-3L). Chemiluminescence was detected using a Gel Imaging System (Tanon).
Preparation of a sfGFP standard curve
To establish a standard curve for the absolute quantification of sfGFP yield, E. coli BL21(DE3) transformed with the pJL1-sfGFP plasmid was inoculated into 5 mL of LB medium containing kanamycin and cultured overnight. Cells were harvested by centrifugation (10,000 × g, 5 min), resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 300 mM NaCl), and disrupted using a high-pressure homogenizer at 800 bar for two passes. The clarified supernatant (10,000 × g, 20 min) was purified via His-tag affinity chromatography, using 30 mM and 300 mM imidazole for washing and elution, respectively, with purity confirmed by SDS-PAGE.
The purified sfGFP was quantified via an Enhanced BCA Protein Assay Kit (Beyotime) and serially diluted in 50 mM HEPES buffer (pH 7.5) to concentrations ranging from 0.042 to 0.68 mg/mL. Fluorescence was measured using a Cytation 5 Multi-Mode Microplate Reader (BioTek) at an excitation of 485 nm and emission of 528 nm in flat-bottom 96-well half-area black plates. Each dilution was tested in triplicate to generate a standard curve for converting fluorescence intensity into absolute protein concentration (mg/mL).
Expression and purification of vimentin and BsaI
The gene for human vimentin (GenBank NP_003371.2) was sub-cloned into the pET507a vector for expression. BsaI (4 mL reaction) and vimentin (1 mL reaction) proteins were synthesized using a CFPS system. The core reaction mixture for both proteins consisted of 16 mM magnesium glutamate, 250 mM potassium glutamate, 1.2 mM ATP, 2.4 mM GTP, 80 mM CrP, 125 μg/mL CrK, 13.3 ng/μL or 7.2 ng/μL DNA template, and 50% cell extract.
For BsaI purification, the 4 mL reaction mixture was centrifuged at 20,000 × g, and the supernatant was incubated with 600 μL of Ni beads for 1 h at 4°C. The beads were washed five times with 2 mL of wash buffer (40 mM HEPES-KOH pH 7.5, 50 mM imidazole, 500 mM NaCl). Elution was performed with 2 mL of elution buffer (40 mM HEPES-KOH pH 7.5, 500 mM imidazole, 500 mM NaCl). The eluted BsaI was desalted using a column (desalting buffer: 40 mM HEPES-KOH pH 7.5, 500 mM NaCl, 1 mM DTT), concentrated to 1 mg/mL, and stored at –80°C in the presence of 10% glycerol. BsaI enzymatic activity was validated in a 20 μL reaction containing 2 μL of 10x rCutsmart (NEB), 2 μg of a substrate plasmid, and BsaI enzyme diluted in a 10-fold gradient. The reaction was incubated at 37°C for 1 h and visualized via agarose gel electrophoresis.
Vimentin synthesis was carried out in a 5 mL nuclease-free tube with static incubation at 37°C for 13 h. The BsaI synthesis was performed in a 10 mL nuclease-free tube at 30°C with shaking at 150 rpm for 13 h.
Vimentin filament assembly
Vimentin, expressed via eCFPS, was refolded and prepared for assembly through a multi-step gradient dialysis protocol. The protein was dialyzed at room temperature in a buffer (5 mM Tris−HCl pH 8.5, 1 mM EDTA, 0.1 mM EGTA, 5 mM β-ME) sequentially containing 6 M, 4 M, and 2 M urea, with each step lasting 30 min. Subsequent overnight dialysis was performed at 4°C in the same buffer lacking urea. The protein was finally dialyzed for 1 h at room temperature into 5 mM Tris pH 8.5, 5 mM β-ME, ensuring the protein was in its tetramer configuration, after which the sample was concentrated. To initiate filament assembly, 20 μL of the concentrated protein solution was quickly mixed with 20 μL of assembly buffer (5 mM Tris pH 8.5, 170 mM NaCl, 100 mM KCl, 5 mM MgCl2) in a 200 μL PCR tube. The assembly reaction was incubated for 1 h in a PCR thermocycler preheated to 25°C before being immediately transferred to ice. Filament formation was subsequently verified by negative-stain transmission electron microscopy.
Negative-staining transmission electron microscopy (TEM)
Samples from vimentin assembly, the TEM samples were prepared by negative staining. A glow-discharged, carbon-coated copper grid was first rinsed with 3 μL of protein buffer (5 mM Tris pH 8.5, 5 mM β−ME). Then, 3 μL of the assembled sample solution was incubated on the grid for 20 s. The sample was fixed using 3 μL of 0.8% glutaraldehyde solution for 20 s. Finally, the grid was stained twice with 3 μL of uranyl acetate solution, with each staining step lasting 90 s. Samples were observed using a Talos F200C transmission electron microscope at a nominal magnification of 92,000.
Samples from the SDG were prepared for TEM. Fresh, glow-discharged carbon-coated grids were immersed in 3 μL of the corresponding sample for 2 min. Excess solvent was removed, and the grids were stained with uranyl acetate for 1 min and air dried.
Sucrose density gradient (SDG) analysis
A volume of 170–180 μL of lysate was loaded onto a 10–40% (w/w) SDG. The gradient buffer contained 10 mM HEPES-KOH (pH 7.5), 14 mM Mg(OAc)₂, 60 mM KOAc. The gradient was prepared using a simple diffusion method (Biocomp) and centrifugation at 38,000 rpm for 2.5 h at 4°C in a Beckman SW41Ti rotor. Following centrifugation, the gradient was fractionated using a density gradient fractionation system (Biocomp), with continuous monitoring of the absorbance at 260 nm.
Statistics
GraphPad Prism v.8.0 was used to perform statistical analysis. Significance was determined by comparing two groups using the t-test analysis, and p<0.05 was considered statistically significant. The data are represented as the mean ± SEM. The numbers of technical replicates or biological replicates for each group are indicated in the figure legends.
Data availability
All data generated or analyzed during this study are included in the manuscript and the supplementary information. Specifically, source data files have been provided for all figures, and the optimized reaction components and concentrations are detailed in the main text and Supplementary Files. All plasmids and linear DNA templates used are described in the Methods section.
References
-
Elongation in translation as a dynamic interaction among the ribosome, tRNA, and elongation factors EF-G and EF-TuQuarterly Reviews of Biophysics 42:159–200.https://doi.org/10.1017/S0033583509990060
-
A highly optimized human in vitro translation systemCell Reports Methods 4:100755.https://doi.org/10.1016/j.crmeth.2024.100755
-
An economical method for cell-free protein synthesis using glucose and nucleoside monophosphatesBiotechnology Progress 21:1146–1153.https://doi.org/10.1021/bp050052y
-
Cell-free protein synthesis: Applications come of ageBiotechnology Advances 30:1185–1194.https://doi.org/10.1016/j.biotechadv.2011.09.016
-
Macromolecular crowding by polyethylene glycol reduces protein breathingThe Journal of Physical Chemistry Letters 14:2599–2605.https://doi.org/10.1021/acs.jpclett.3c00271
-
Cyclic AMP signaling and gene regulationAnnual Review of Nutrition 18:353–383.https://doi.org/10.1146/annurev.nutr.18.1.353
-
Processing of tRNA in prokaryotes and eukaryotesCRC Critical Reviews in Biochemistry 17:45–71.https://doi.org/10.3109/10409238409110269
-
Vimentin filaments integrate low-complexity domains in a complex helical structureNature Structural & Molecular Biology 31:939–949.https://doi.org/10.1038/s41594-024-01261-2
-
Cell-free protein synthesis at high temperatures using the lysate of a hyperthermophileJournal of Biotechnology 126:186–195.https://doi.org/10.1016/j.jbiotec.2006.04.010
-
Creatine phosphate administration in cell energy impairment conditions: A summary of past and present researchHeart, Lung & Circulation 26:1026–1035.https://doi.org/10.1016/j.hlc.2016.12.020
-
Recent advances in cell-free unnatural protein synthesisSheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology 34:1371–1385.https://doi.org/10.13345/j.cjb.180203
-
Unfolding of Escherichia coli ribosomes by removal of magnesiumJournal of Molecular Biology 18:356–371.https://doi.org/10.1016/s0022-2836(66)80253-x
-
A user’s guide to cell-free protein synthesisMethods and Protocols 2:24.https://doi.org/10.3390/mps2010024
-
Constructing cell-free expression systems for low-cost accessACS Synthetic Biology 11:1114–1128.https://doi.org/10.1021/acssynbio.1c00342
-
Cell-free gene expression: methods and applicationsChemical Reviews 125:91–149.https://doi.org/10.1021/acs.chemrev.4c00116
-
Cell-free protein synthesis enabled rapid prototyping for metabolic engineering and synthetic biologySynthetic and Systems Biotechnology 3:90–96.https://doi.org/10.1016/j.synbio.2018.02.003
-
Development of a robust Escherichia coli-based cell-free protein synthesis application platformBiochemical Engineering Journal 165:107830.https://doi.org/10.1016/j.bej.2020.107830
-
The past, present and future of cell-free protein synthesisTrends in Biotechnology 23:150–156.https://doi.org/10.1016/j.tibtech.2005.01.003
-
Prolonging cell-free protein synthesis with a novel ATP regeneration systemBiotechnology and Bioengineering 66:180–188.
-
Prolonging cell-free protein synthesis by selective reagent additionsBiotechnology Progress 16:385–390.https://doi.org/10.1021/bp000031y
-
Tuning the cell-free protein synthesis system for biomanufacturing of monomeric human filaggrinFrontiers in Bioengineering and Biotechnology 8:590341.https://doi.org/10.3389/fbioe.2020.590341
-
Escherichia coli-based cell-free protein synthesis: protocols for a robust, flexible, and accessible platform technologyJournal of Visualized Experiments 144:e58882.https://doi.org/10.3791/58882-v
-
Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like moleculeNature Structural & Molecular Biology 26:501–509.https://doi.org/10.1038/s41594-019-0236-8
-
Adding new chemistries to the genetic codeAnnual Review of Biochemistry 79:413–444.https://doi.org/10.1146/annurev.biochem.052308.105824
-
The Hsp70-Chaperone machines in bacteriaFrontiers in Molecular Biosciences 8:694012.https://doi.org/10.3389/fmolb.2021.694012
-
Osmolyte-induced folding and stability of proteins: Concepts and characterizationIranian Journal of Pharmaceutical Research 18:13–30.https://doi.org/10.22037/ijpr.2020.112621.13857
-
Mg2+, K+, and the ribosomeJournal of Bacteriology 196:3817–3819.https://doi.org/10.1128/JB.02297-14
-
Translation in prokaryotesCold Spring Harbor Perspectives in Biology 10:a032664.https://doi.org/10.1101/cshperspect.a032664
-
Regulating gene transcription in response to cyclic AMP elevationCellular Signalling 20:460–466.https://doi.org/10.1016/j.cellsig.2007.10.005
-
A novel cell-free protein synthesis systemJournal of Biotechnology 110:257–263.https://doi.org/10.1016/j.jbiotec.2004.02.014
-
IRES-mediated Pichia pastoris cell-free protein synthesisBioresources and Bioprocessing 10:35.https://doi.org/10.1186/s40643-023-00653-4
-
Structures of restriction endonuclease HindIII in complex with its cognate DNA and divalent cationsActa Crystallographica. Section D, Biological Crystallography 65:1326–1333.https://doi.org/10.1107/S0907444909041134
-
Nucleotide sequence of Escherichia coli pyrG encoding CTP synthetaseThe Journal of Biological Chemistry 261:5568–5574.
-
An economical method for producing stable-isotope labeled proteins by the E. coli cell-free systemJournal of Biomolecular NMR 48:193–201.https://doi.org/10.1007/s10858-010-9455-3
Article and author information
Author details
Funding
National Key Research and Development Program of China (2022YFA0807100)
- Wenfei Li
National Natural Science Foundation of China (32171291)
- Wenfei Li
National Natural Science Foundation of China (32371351)
- Wenfei Li
Shandong Basic Research Special Zone (YDZX2024154)
- Wenfei Li
Shandong Basic Research Special Zone (YDZX2025154)
- Wenfei Li
Nature Science Foundation of Shandong Province (ZR2021QC002)
- Wenfei Li
Shandong Excellent Young Scientists Fund Program (2022HWYQ-025)
- Wenfei Li
Taishan Scholars Program (tsqnz20221104)
- Wenfei Li
Cutting Edge Development Fund of Advanced Medical Research Institute (GYY2023QY01)
- Wenfei Li
Shandong University (Cheeloo Youth Program)
- Wenfei Li
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
We thank Alexey Amunts for helpful discussions. We also thank Jian Li and Wanqiu Liu from Shanghai Tech University for providing the endonuclease plasmids and sharing the linear fragment construction method. This work was supported by grants from the National Key Research and Development Program of China (2022YFA0807100), National Natural Science Foundation of China (32171291 and 32371351), Shandong Basic Research Special Zone (Basic Medical Sciences YDZX2024154 and YDZX2025154), Nature Science Foundation of Shandong Province (ZR2021QC002), the Shandong Excellent Young Scientists Fund Program (2022HWYQ-025), Taishan Scholars Program (tsqnz20221104), Cutting Edge Development Fund of Advanced Medical Research Institute (GYY2023QY01), and the Cheeloo Youth Program of Shandong University to WL.
Version history
Cite all versions
You can cite all versions using the DOI https://doi.org/10.7554/eLife.109495. This DOI represents all versions, and will always resolve to the latest one.
Copyright
© 2025, Lang, Zhang et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,472
- views
-
- 585
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.